RxDoctor Payments Data

John Morris, MD

Gastroenterology · Baltimore, MDNPI 1912224957

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (48.6%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 91.8% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2023 at $17,448 and has fallen 98.5% since, to $255 in 2025. Among gastroenterology clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$21,855in general payments, 2019–2025

Across 63 payments — averaging $346.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$20K
  • Olympus Corporation Of The Americas$1K
  • Merit Medical Systems Inc$700
  • Medtronic$89
$2,565in research payments, 2019–2025

Across 1 payment — averaging $2565.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Clovis Oncology, Inc.$3K

What the payments were for

  • Consulting fees$5,37525%
  • Speaking & faculty fees$10,62549%
  • Travel & lodging$4,47820%
  • Food & beverage$1,3786%

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$21,855 in reported general payments places this provider in the 90th percentile of 455 gastroenterology providers in Maryland.

See all gastroenterology providers in Maryland →

Medicare billing

Part B allowed, 2024
$101,017
Medicare patients
233
Services billed
638

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Levothyroxine Sodium12$80
Levofloxacin25$41

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Baltimore

See the full list for Maryland →

Where these figures come from

Is this you, or does something look wrong? →